101
|
Iizuka M, Kishimoto Y, Saita E, Suzuki K, Toyozaki M, Nagai M, Murakami K, Sugihara N, Takenaka K, Tani M, Kondo K. Abstract: P717 THE EFFECT OF BALSAMIC VINEGAR ON LDL OXIDATION AND FOAM CELL FORMATION. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)70885-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
102
|
Kishimoto Y, Hirata Y, Suzuki K, Takenaka K, Iizuka M, Saita E, Toyozaki M, Nagai M, Murakami K, Sugihara N, Taguchi C, Kido T, Kitadate K, Wakame K, Tani M, Kondo K. Abstract: 603 EFFECTS OF LYCHEE POLYPHENOL ON POSTPRANDIAL SERUM LIPID RESPONSES IN HEALTHY HUMAN SUBJECTS. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)70352-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
103
|
Tani M, Kishimoto Y, Iizuka M, Saita E, Suzuki K, Toyozaki M, Nagai M, Murakami K, Sugihara N, Takenaka K, Taguchi C, Kido T, Yoshida M, Kondo K. Abstract: P695 LEMON FLAVONOIDS REDUCE HOMOCYSTEINE-INDUCED MONOCYTE INFLAMMATION. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)70863-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
104
|
Nagai M, Kishimoto Y, Iizuka M, Saita E, Suzuki K, Toyozaki M, Murakami K, Sugihara N, Takenaka K, Taguchi C, Kido T, Tani M, Kondo K. Abstract: P1427 EFFECTS OF SWEET POTATO (IPOMOEA BATATAS L.) LEAVES ON LDL OXIDATION AND ROS PRODUCTION. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71435-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
105
|
Saita E, Kishimoto Y, Iizuka M, Suzuki K, Toyozaki M, Nagai M, Murakami K, Sugihara N, Takenaka K, Tani M, Kondo K. Abstract: P1429 THE ANTIOXIDANT ACTIVITIES OF PERILLA FRUTESCENS AGAINST LDL OXIDATION IN VITRO AND IN VIVO. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71437-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
106
|
Iizuka T, Sakai H, Moriyama H, Suto N, Nagai M, Bagchi D. Vasorelaxant effects of forsythide isolated from the leaves of Forsythia viridissima on NE-induced aortal contraction. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2009; 16:386-390. [PMID: 19019645 DOI: 10.1016/j.phymed.2008.09.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2008] [Revised: 08/13/2008] [Accepted: 09/04/2008] [Indexed: 05/27/2023]
Abstract
Forsythide (F1) isolated from the leaves of Forsythia viridissima (Oleaceae) showed vasorelaxant effects on norepinephrine (NE)-induced contraction of rat aorta with or without endothelium. This compound did not affect contraction induced by high concentration potassium (60 mM K(+)) and phorbol 12,13-diacetate, but inhibited NE-induced contraction in the presence of nicardipine. These results demonstrated the inhibitory effects of F1 on NE-induced vasocontraction presumably due to decrease of calcium influx from extracellular area, which was induced by NE.
Collapse
|
107
|
Okamoto K, Kihira T, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, Sakamoto N, Inaba Y, Nagai M. Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology 2009; 32:251-6. [PMID: 19209004 DOI: 10.1159/000201563] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2008] [Accepted: 11/01/2008] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND There has been little interest in the role of nutrition in the prevention of amyotrophic lateral sclerosis (ALS). We investigated the relationship between dietary intake of vegetables, fruit, and antioxidants and the risk of ALS in Japan. METHODS Between 2000 and 2004, we recruited 153 ALS patients aged 18-81 years with disease duration of 3 years within the study period in accordance with El Escorial World Federation of Neurology criteria. Three hundred and six gender- and age-matched controls were randomly selected from the general population. Information on dietary factors was collected using a validated self-administered diet history questionnaire. RESULTS A higher consumption of all fruits and vegetables and fruit alone in the highest quartiles was associated with a statistically significantly reduced risk of ALS. Although not statistically significant, a beneficial association between intake of all vegetables, green and yellow vegetables and other vegetables and ALS was found. No statistically significant dose-response relationship was observed between intake of beta-carotene, vitamin C and vitamin E and the risk of ALS. CONCLUSION Our findings suggest that higher intake of food rich in antioxidants such as fruit and vegetables confer protection against the development of ALS.
Collapse
|
108
|
Katayama Y, Misawa A, Yamada N, Yachi S, Muto H, Aoki T, Kawabata Y, Nagai M. Analysis of antimony around the abandoned Tsugu mine in Aichi Prefecture by neutron activation analysis. J Radioanal Nucl Chem 2008. [DOI: 10.1007/s10967-008-9503-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
109
|
Kawabata Y, Aparin V, Nagai M, Yamamoto M, Shiraishi K, Katayama Y. Uranium and thorium isotopes from Kazakhstan. J Radioanal Nucl Chem 2008. [DOI: 10.1007/s10967-008-0904-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
110
|
Hisano J, Nagai M, Paradisi P. Electric dipole moments from flavor-changing supersymmetric soft terms. Int J Clin Exp Med 2008. [DOI: 10.1103/physrevd.78.075019] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
111
|
Nishikawa N, Nagai M, Moritoyo T, Yabe H, Nomoto M. Plasma amantadine concentrations in patients with Parkinson's disease. Parkinsonism Relat Disord 2008; 15:351-3. [PMID: 18823813 DOI: 10.1016/j.parkreldis.2008.08.005] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2008] [Revised: 07/31/2008] [Accepted: 08/08/2008] [Indexed: 11/24/2022]
Abstract
We determined plasma amantadine concentrations in patients with Parkinson's disease (PD) in daily clinical practice and investigated the relationship between plasma concentration and adverse reactions to clarify the safe therapeutic range. Seventy-eight consecutive PD patients on stable amantadine treatment were recruited. Plasma concentration of amantadine was measured 3h after the administration of morning amantadine dose. Serum creatinine was measured to estimate renal function. The mean daily dose of amantadine was 135.1+/-62.3mg/day, and the mean plasma amantadine concentration was 812.5+/-839.5 ng/ml (range, 91-4400 ng/ml). Plasma amantadine concentration increased according to increasing renal dysfunction. Three patients exhibited adverse reactions, such as myoclonus, hallucinations, and delirium, and all of them showed plasma amantadine concentration >3000 ng/ml. None of the three cases had previously shown such side effects. PD patients who have not developed any psychiatric symptoms as adverse reactions to the treatment may develop myoclonus, hallucination, or delirium when the plasma concentration of amantadine exceeds 3000 ng/ml. It is therefore recommended to use amantadine at the plasma concentration of less than 3000 ng/ml in the treatment of Parkinson's disease, especially in elderly patients.
Collapse
|
112
|
Torii S, Kamiyama T, Muroya T, Sato S, Sagehashi H, Kobayashi Y, Suzuki J, Nagai M, Muto S, Oikawa K, Mori K, Yonemura M, Ishigaki T, Ikeda S. Super high resolution powder diffractometer at J-PARC. Acta Crystallogr A 2008. [DOI: 10.1107/s0108767308093628] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
113
|
Nagai M, Karunakara U, Rowley E, Burnham G. Violence against refugees, non-refugees and host populations in southern Sudan and northern Uganda. Glob Public Health 2008. [DOI: 10.1080/17441690701768904] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
114
|
Zhu BT, Shim JY, Nagai M, Bai HW. Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (-)-epigallocatechin-3-O-gallate. Xenobiotica 2008; 38:130-46. [PMID: 18197555 DOI: 10.1080/00498250701744641] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
The molecular mechanism of inhibition of human catechol-O-methyltransferase (COMT) by (-)-epigallocatechin-3-O-gallate (EGCG), which is a modest substrate of COMT but an ultra-potent inhibitor of this enzyme, was studied. EGCG has an IC(50) value of 70 nM for inhibiting human liver COMT-mediated O-methylation of 2-hydroxyestradiol, which was 210-760 times more potent than catechin, epigallocatechin and epicatechin. Kinetic analyses showed that EGCG had a strong component of non-competitive inhibition of the O-methylation of 2-hydroxyestradiol. Computational molecular modelling studies showed that the B- and D-rings of EGCG can bind tightly to the human COMT in four different modes (i.e. D-para-OH, D-meta-OH, B-para-OH, and B-meta-OH). The binding geometry of EGCG in these binding modes was found to be less than ideal to form perfect Mg(2+) coordination for the catalysis of its own methylation. It is concluded that the very tight binding interaction of EGCG with COMT makes it a potent non-competitive inhibitor, but its imperfect geometry makes it a poor substrate for methylation by this enzyme.
Collapse
|
115
|
Nagai M, Brentani M. Gene Expression Profiles in Breast Cancer to Identify Estrogen Receptor Target Genes. Mini Rev Med Chem 2008; 8:448-54. [DOI: 10.2174/138955708784223503] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
116
|
Yamakado K, Takaki H, Nakatsuka A, Nagai M, Matsuda S, Suzuki H, Takeda K. Case report: Radiofrequency ablation for the treatment of painful isolated wound recurrence after resection of gastric cancer. Br J Radiol 2008; 81:e100-2. [PMID: 18344264 DOI: 10.1259/bjr/17144155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
A 75-year-old woman underwent radiofrequency (RF) ablation for the treatment of two painful disseminated tumours that appeared and rapidly became larger at the anterior abdominal wound 16 months after she had undergone surgery for gastric cancer. RF ablation was performed under CT-fluoroscopic guidance for both tumours, which measured 5 cm and 3 cm in maximum diameter. Pain was relieved immediately after RF ablation, and both tumours showed significant involution upon physical examination and CT studies. The patient is still alive 15 months after RF ablation, with no evidence of tumour recurrence.
Collapse
|
117
|
Hida T, Shikata K, Tokuhara N, Ishibashi A, Nagai M, Yamauchi T, Kobayashi S. Immunosuppressive effect of ER-38925, a retinoic acid receptor subtype α-selective agonist, in mouse models of human graft-vs-host disease. Drug Discov Ther 2008; 2:35-44. [PMID: 22504453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Graft-vs-host disease (GVHD) is a devastating disorder that determines the prognosis of patients who receive a bone marrow transplant. GVHD is caused by donor cells responding to host disparate MHC alleles. In this report, we demonstrate that ER-38925, a newly discovered retinoid agonist with selectivity to retinoic acid receptor subtype α (RAR-α), is a potent immunosuppressive agent in mouse models of human GVHD. In a mouse model of lethal acute GVHD (aGVHD), ER-38925 prolonged the lifespan of the recipient mice in a dose-dependent manner. Its effect at 1 mg/kg was almost comparable to that of cyclosporin A at 30 mg/kg. ER-38925 profoundly prevented the development of antiallogeneic cytotoxic T lymphocyte (CTL) response in the mouse model of aGVHD at 0.1 and 0.3 mg/kg. It strongly inhibited in vitro proliferation of alloantigenstimulated donor T lymphocytes, and RAR-α seemed to play an exclusive role in this effect since inhibition by all-trans retinoic acid, which can activate all subtypes of RAR, was completely reversed by an RAR-α selective antagonist. Moreover, it significantly inhibited the elevation of serum IL-12 and IFN-γ and LPS-induced serum TNF-α elevation, all of which are known to be crucial disease-exacerbating factors in this model and human GVHD, in the mouse model of aGVHD. These results suggest that ER-38925 prevents the development of aGVHD through substantial inhibition of anti-allogeneic responses of donor T lymphocytes. In addition, in vivo administration of ER-38925 also blocked serum anti-DNA autoantibody production in a mouse model of human chronic GVHD. This is the first report to clearly show the remarkable immunosuppressive effects of an RAR-α selective agonist in mouse models of human GVHD. These findings may allow an RAR-αselective agonist like ER-38925 to serve as a novel therapy to prevent both acute and chronic types of human GVHD.
Collapse
|
118
|
Hayashi T, Wang XQ, Zhang HZ, Deguchi K, Nagotani S, Sehara Y, Tsuchiya A, Nagai M, Shoji M, Abe K. Induction of platelet derived-endothelial cell growth factor in the brain after ischemia. Neurol Res 2007; 29:463-8. [PMID: 17535565 DOI: 10.1179/016164107x164139] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
OBJECTIVES Platelet derived-endothelial cell growth factor (PD-ECGF) is a highly potent angiogenic factor. Although angiogenesis plays an active role in pathophysiology of stroke, the expression pattern of this molecule in ischemic brain has not been investigated. In the present study, therefore, we investigated the change of PD-ECGF expression in the brain after ischemia. METHODS Using male Wistar rats, the right middle cerebral artery was occluded by a nylon thread for 90 minutes. The animals were decapitated 3 hours, 1, 4 and 10 days after the reperfusion, and frozen sections were prepared. We then performed immunohistochemistry for PD-ECGF and identified the cell phenotype which strongly expressed it by fluorescent double staining. RESULTS In the sham-operated brain, only small numbers of cells slightly expressed PD-ECGF. The number of positively stained cells increased at the peri-ischemic area from hour 3 of reperfusion. Not only small-sized cells but also large-sized cells became stained. The number of stained cells further increased, and peaked at day 4 for large-sized cells and at day 10 as to small-sized cells. Fluorescent double staining revealed that both large-sized and small-sized cells were neurons, indicating that neurons are the main source of PD-ECGF production in the ischemic brain. DISCUSSION PD-ECGF has a strong angiogenic property without vascular permeability increasing effect. This molecule may have a therapeutic potential for ischemic stroke treatment.
Collapse
|
119
|
Gao YF, Nagai M, Seo WS, Koumoto K. Thick transparent rutile TiO2 films crystallized in solution. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2007; 23:4712-4. [PMID: 17373833 DOI: 10.1021/la0635404] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
We report a novel process for the preparation of dense, transparent TiO2 films of 2.5 mum thickness on a F-doped SnO2-covered glass substrate. The starting solution contained peroxotitanate complex ions, which are relatively stable under the experimental conditions, permitting the deposition of highly textured rutile nanocrystalline films. The nanocrystals exhibit specific orientations along the (101) and (002) crystalline planes. Kinetic studies suggest that the precipitation started from the formation of amorphous solids, followed by crystallization through a dissolution-recrystallization process. Although a minor phase of anatase was detected only for powders collected from solutions after film preparation, not for films, the transformation from amorphous to anatase was believed to occur before further transformation of anatase to rutile. The present method enables film synthesis on a surface with a large area, and therefore could be integrated into the processing of electroluminescent devices.
Collapse
|
120
|
Nagai M, Kishi K, Kato S. Insular cortex and neuropsychiatric disorders: A review of recent literature. Eur Psychiatry 2007; 22:387-94. [PMID: 17416488 DOI: 10.1016/j.eurpsy.2007.02.006] [Citation(s) in RCA: 239] [Impact Index Per Article: 14.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2006] [Revised: 02/04/2007] [Accepted: 02/16/2007] [Indexed: 10/23/2022] Open
Abstract
AbstractThe insular cortex is located in the centre of the cerebral hemisphere, having connections with the primary and secondary somatosensory areas, anterior cingulate cortex, amygdaloid body, prefrontal cortex, superior temporal gyrus, temporal pole, orbitofrontal cortex, frontal and parietal opercula, primary and association auditory cortices, visual association cortex, olfactory bulb, hippocampus, entorhinal cortex, and motor cortex. Accordingly, dense connections exist among insular cortex neurons. The insular cortex is involved in the processing of visceral sensory, visceral motor, vestibular, attention, pain, emotion, verbal, motor information, inputs related to music and eating, in addition to gustatory, olfactory, visual, auditory, and tactile data. In this article, the literature on the relationship between the insular cortex and neuropsychiatric disorders was summarized following a computer search of the Pub-Med database. Recent neuroimaging data, including voxel based morphometry, PET and fMRI, revealed that the insular cortex was involved in various neuropsychiatric diseases such as mood disorders, panic disorders, PTSD, obsessive-compulsive disorders, eating disorders, and schizophrenia. Investigations of functions and connections of the insular cortex suggest that sensory information including gustatory, olfactory, visual, auditory, and tactile inputs converge on the insular cortex, and that these multimodal sensory information may be integrated there.
Collapse
|
121
|
Yabe H, Nisikawa N, Kaneda M, Nagai M, Moritoyo H, Moritoyo T, Nomoto M. 1.323 Siblings of SCA type 2 with heterogenous neurodegenerative disorders. Parkinsonism Relat Disord 2007. [DOI: 10.1016/s1353-8020(08)70558-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
122
|
Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, Conte-Devolx B, Regis J, Brue T. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur J Endocrinol 2007; 156:91-8. [PMID: 17218730 DOI: 10.1530/eje.1.02323] [Citation(s) in RCA: 136] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Though transsphenoidal surgery remains the first-line treatment of Cushing's disease, recurrence occurs frequently. Conventional radiotherapy and anticortisolic drugs both have adverse effects. Stereotactic radiosurgery needs to be evaluated more precisely. The aim of this study was to determine long-term hormonal effects and tolerance of gamma knife (GK) radiosurgery in Cushing's disease. DESIGN Forty patients with Cushing's disease treated by GK were prospectively studied over a decade, with a mean follow-up of 54.7 months. Eleven of them were treated with GK as a primary treatment. METHODS Radiosurgery was performed at the Department of Functional Neurosurgery of Marseille, France, using the Leksell Gamma Unit B and C models. Median margin dose was 29.5 Gy. Patients were considered in remission if they had normalized 24-h free urinary cortisol and suppression of plasma cortisol after low-dose dexamethasone suppression test. RESULTS Seventeen patients (42.5%) were in remission after a mean of 22 months (range 12-48 months). The two groups did not differ in terms of initial hormonal levels. Target volume was significantly higher in uncured than in remission group (909.8 vs 443 mm(3), P = 0.038). We found a significant difference between patients who were on or off anticortisolic drugs at the time of GK (20 vs 48% patients in remission respectively, P = 0.02). CONCLUSION With 42% of patients in remission after a median follow-up of 54 months, GK stereotactic radiosurgery, especially as an adjunctive treatment to surgery, may represent an alternative to other therapeutic options in view of their adverse effects.
Collapse
|
123
|
Kunitake T, Nagai M, Yanagi H, Takarabe K, Nakashima N. Bilayer Formation by Aggregation of Polymeric Amphiphiles. ACTA ACUST UNITED AC 2006. [DOI: 10.1080/00222338408056600] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
124
|
Kawabata Y, Yamamoto M, Aparin V, Ko S, Shiraishi K, Nagai M, Katayama Y. Uranium pollution of water in the western part of Uzbekistan. J Radioanal Nucl Chem 2006. [DOI: 10.1007/s10967-006-0320-5] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
125
|
Gao YF, Nagai M, Masuda Y, Sato F, Seo WS, Koumoto K. Surface precipitation of highly porous hydrotalcite-like film on Al from a zinc aqueous solution. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2006; 22:3521-7. [PMID: 16584223 DOI: 10.1021/la052424i] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
A hydrotalcite-like film has been successfully deposited on an Al-bearing glass substrate based on an interface reaction between an Al layer and a zinc aqueous solution. The film selectively grew on the Al surface but not on the glass surface. The film on Al was composed of layered nanosheets of a hydrotalcite-like compound containing Al and Zn. Comparably, deposits on the plastic surface and precipitates in solution were wurzite-type ZnO with various morphologies depending upon the preparation conditions. At low supersaturation degrees, single crystals and superstructures of Zn-Al hydrotalcite were also obtained. This porous hydrotalcite film has a potential application as catalyst supports, environmental materials, or matrixes for hydrotalcite-based nanocomposite films. Using Al as a reaction interface makes it easy to coat porous hydrotalcites on a series of matrix materials varying in shapes and properties, which is important for achieving practical applications. In addition, the method developed should be widely applicable to other systems for the preparation of porous or oriented hydrotalcite-like thin films by an appropriate combination of divalent/trivalent solution-substrate systems.
Collapse
|